Search
Close this search box.

Personalized mRNA vaccine boosts melanoma immunotherapy

  • RESEARCH HIGHLIGHT
  • 25 January 2024

In patients with resected, high-risk melanoma, the addition of a personalized mRNA-based neoantigen therapy to adjuvant pembrolizumab was more effective than pembrolizumab alone.